1. Academic Validation
  2. Noncanonical translation via deadenylated 3' UTRs maintains primordial germ cells

Noncanonical translation via deadenylated 3' UTRs maintains primordial germ cells

  • Nat Chem Biol. 2018 Sep;14(9):844-852. doi: 10.1038/s41589-018-0098-0.
Youngnam N Jin 1 2 3 4 5 6 Peter J Schlueter 7 8 9 Nathalie Jurisch-Yaksi 7 8 9 Pui-Ying Lam 7 8 9 10 11 12 Shan Jin 7 8 9 Woong Y Hwang 7 8 Jing-Ruey Joanna Yeh 7 8 9 Masaaki Yoshigi 13 Shao-En Ong 11 14 Monica Schenone 11 Christina R Hartigan 11 Steven A Carr 11 Randall T Peterson 15 16 17 18 19 20
Affiliations

Affiliations

  • 1 Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA, USA. youngnam.jin@pharm.utah.edu.
  • 2 Department of Medicine, Massachusetts General Hospital, Charlestown, MA, USA. youngnam.jin@pharm.utah.edu.
  • 3 Department of Medicine, Harvard Medical School, Boston, MA, USA. youngnam.jin@pharm.utah.edu.
  • 4 Department of Systems Biology, Harvard Medical School, Boston, MA, USA. youngnam.jin@pharm.utah.edu.
  • 5 Broad Institute, Cambridge, MA, USA. youngnam.jin@pharm.utah.edu.
  • 6 College of Pharmacy, University of Utah, Salt Lake City, UT, USA. youngnam.jin@pharm.utah.edu.
  • 7 Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA, USA.
  • 8 Department of Medicine, Massachusetts General Hospital, Charlestown, MA, USA.
  • 9 Department of Medicine, Harvard Medical School, Boston, MA, USA.
  • 10 Department of Systems Biology, Harvard Medical School, Boston, MA, USA.
  • 11 Broad Institute, Cambridge, MA, USA.
  • 12 College of Pharmacy, University of Utah, Salt Lake City, UT, USA.
  • 13 Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.
  • 14 Department of Pharmacology, University of Washington, Seattle, WA, USA.
  • 15 Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA, USA. randall.peterson@pharm.utah.edu.
  • 16 Department of Medicine, Massachusetts General Hospital, Charlestown, MA, USA. randall.peterson@pharm.utah.edu.
  • 17 Department of Medicine, Harvard Medical School, Boston, MA, USA. randall.peterson@pharm.utah.edu.
  • 18 Department of Systems Biology, Harvard Medical School, Boston, MA, USA. randall.peterson@pharm.utah.edu.
  • 19 Broad Institute, Cambridge, MA, USA. randall.peterson@pharm.utah.edu.
  • 20 College of Pharmacy, University of Utah, Salt Lake City, UT, USA. randall.peterson@pharm.utah.edu.
Abstract

Primordial germ cells (PGCs) form during early embryogenesis with a supply of maternal mRNAs that contain shorter poly(A) tails. How translation of maternal mRNAs is regulated during PGC development remains elusive. Here we describe a small-molecule screen with zebrafish embryos that identified primordazine, a compound that selectively ablates PGCs. Primordazine's effect on PGCs arises from translation repression through primordazine-response elements in the 3' UTRs. Systematic dissection of primordazine's mechanism of action revealed that translation of mRNAs during early embryogenesis occurs by two distinct pathways, depending on the length of their poly(A) tails. In addition to poly(A)-tail-dependent translation (PAT), early embryos perform poly(A)-tail-independent noncanonical translation (PAINT) via deadenylated 3' UTRs. Primordazine inhibits PAINT without inhibiting PAT, an effect that was also observed in quiescent, but not proliferating, mammalian cells. These studies reveal that PAINT is an alternative form of translation in the early embryo and is indispensable for PGC maintenance.

Figures
Products